Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2119-2126

  Yuan, Ping ^a,b   Xue, Hong ^a   Zhou, Li ^a   Qu, Linping ^a   Li, Cheng ^b   Wang, Zhen ^a   Ni, Jun ^a   Yu, Chen ^b   Yao, Tai ^a   Huang, Yu ^c   Wang, Rui ^a,d   Lu, Limin ^a  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d LAKEHEAD UNIVERSITY   (Canada)

Author keywords

cystathionine lyase; diabetic nephropathy; hydrogen sulfide; mesangial cell.

Indexed keywords

COLLAGEN TYPE 4; CYSTATHIONINE GAMMA LYASE; GLUCOSE; HYDROGEN SULFIDE; PROPARGYLGLYCINE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FLUORESCENCE ANALYSIS; GENE EXPRESSION; KIDNEY CORTEX; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE IV; DIABETES MELLITUS, EXPERIMENTAL; EXTRACELLULAR MATRIX; GLOMERULAR MESANGIUM; GLUCOSE; HYDROGEN SULFIDE; MALE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWEETENING AGENTS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79960002418     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq749     Document Type: Article

References (39)

1. Steffes MW, Osterby R, Chavers B et al. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 1989; 38: 1077-1081. (Pubitemid 19250390)
2. Davis LK, Rodgers BD, Kelley KMet al. Angiotensin II- and glucosestimulated extracellular matrix production: mediation by the insulinlike growth factor (IGF) axis in a murine mesangial cell line. Endocrine 2008; 33: 32-39.
3. Tan AL, Forbes JM, Cooper ME et al. AGE, RAGE and ROS in diabetic nephropathy. Semin Nephrol 2007; 27: 130-143. (Pubitemid 46550311)
4. Nakajima T, Hasegawa G, Kamiuchi K et al. Differential regulation of intracellular redox state by extracellular matrix proteins in glomerular mesangial cells: potential role in diabetic nephropathy. Redox Rep 2006; 11: 223-230. (Pubitemid 44741629)
5. Wang R. Two's company, three's a crowd-can H2S be the third endogenous gaseous transmitter? FASEB J 2002; 16: 1792-1798. (Pubitemid 35340360)
6. Wu L, YangW, Jia X et al. Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats. Lab Invest 2009; 89: 59-67.
7. Doeller JE, Isbell TS, Benavides G et al. Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal Biochem 2005; 341: 40-51. (Pubitemid 40615718)
8. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996; 16: 1066-1071. (Pubitemid 26140863)
9. Lowicka E, Beltowski J. Hydrogen sulfide (H2S)-the third gas of interest for pharmacologists. Pharmacol Rep 2007; 59: 4-24. (Pubitemid 46522698)
10. Akahoshi N, Lzumi T, Ishizaki Y et al. Differential induction of cystathionine gamma-lyase in the livers and kidneys of mouse dams during gestation and lactation. Bio Pharm Bull 2006; 29: 1799-1802. (Pubitemid 44338397)
11. Teague B, Asiedu S, Moore PK. The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility. Br J Pharmacol 2002; 137: 139-145.
12. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from hemodynamics to molecular pathology. Eur J Clin Invest 2004; 34: 785-796. (Pubitemid 39657924)
13. Li L, Bhatia M, Zhu YZ et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005; 19: 1196-1198. (Pubitemid 40946463)
14. Cai WJ, Wang MJ, Moore PK et al. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovas Res 2007; 76: 29-40. (Pubitemid 47362041)
15. Soulis-Liparota T, Cooper M, Papazoglou D et al. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 1991; 40: 1328-1334.
16. Shi YX, Chen Y, Zhu YZ et al. Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2007; 293: 2093-2100.
17. He M, Zang L, Shao Y et al. Inhibition of renin/prorenin receptor attenuated mesangial cell proliferation and reduced associated fibrotic factor release. Eur J Pharmacol 2009; 606: 151-161.
18. Singh R, Sing AK, Alavi N et al. Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol 2003; 14: 873-880. (Pubitemid 36359269)
19. Xue H, Yuan P, Zhou L et al. Angiotensin II mediates the cell proliferation effect of adrenotensin on cultured rat mesangial cells. Acta Pharmacologica Sinica 2009; 30: 1132-1137.
20. Cai WJ, Wang MJ, Moore PK et al. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 2007; 76: 29-40. (Pubitemid 47362041)
21. Brancaleone V, Roviezzo F, Vellecco V et al. Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. Br J Pharmacol 2008; 155: 673-680.
22. Wang R. Hydrogen sulfide: the third gasotransmitter in biology and medicine. Antioxid Redox Signal 2010; 12: 1061-1064.
23. Wang R. Hydrogen sulfide: a new EDRF. Kidney Int 2009; 76: 700-704.
24. Sen U, Basu P, Abe OA et al. Hydrogen sulfide ameliorates hyperhomocysteinemia- associated chronic renal failure. Am J Physiol Renal Physiol 2009; 297: F410-F419.
25. Xia M, Chen L, Muh RW et al. Production and action of hydrogen sulfide, a novel gaseous bioactive substance, in the kidney. J Pharmacol Exp Ther 2009; 329: 1056-1062.
26. Tripatara P, Patel NS, Collino M et al. Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 2008; 88: 1038-1048.
27. Lu M, Liu YH, Goh HS et al. Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol 2010; 21: 993-1002.
28. Carey RM, Siragy HM. The intrarenal rennin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 2003; 14: 274-281. (Pubitemid 36992197)
29. Vidotti DB, Casarini DE, Cristovam PC et al. High glucose concentration stimulates intracellular rennin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 2004; 286: 1039-1045.
30. Jain SK, Bull R, Rains JL et al. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal 2010; 12: 1333-1337.
31. Jiang Z, Seo JY, Ha H et al. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 upregulation in mesangial cells and in diabetic kidney. Biochem Biophys Res Commun 2003; 309: 961-966. (Pubitemid 37122623)
32. Ziyadeh FN, Hoffman BB, Han DC et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000; 97: 8015-8020. (Pubitemid 30460765)
33. Fogo AB. Progression and potential regression of glomerulosclerosis. Kidney Int 2001; 59: 804-819. (Pubitemid 32157952)
34. Suzaki Y, Yoshizumi M, Kagami S et al. BMK 1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Kidney Int 2004; 65: 1749-1760. (Pubitemid 38591023)
35. Rosen P, Nawroth PP, King G et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001; 17: 189-212. (Pubitemid 32624602)
36. Ha H, Lee HB. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 2000; 58: 19-25.
37. Oh JH, Ha H, Yu MR et al. Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis. Kidney Int 1998; 54: 1872-1878. (Pubitemid 28533615)
38. Hua H, Goldberg HJ, Fantus IG et al. High glucose-enhanced mesangial cell extracellular signal-regulated protein kinase activation and α1 (IV) collagen expression in response to endothelin-1 role of specific protein Kinase C isozymes. Diabetes 2001; 50: 2376-2383. (Pubitemid 33641925)
39. Yan SK, Chang T, Wang H et al. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun 2006; 351: 485-491 (Pubitemid 44755144)